New and not so new vaccines

BMJ

Volumn 313, Issue 7060, 1996, Pages 768-

  Jefferson, Tom ^a  

^a MINISTRY OF DEFENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; MONOCLONAL ANTIBODY;

EDITORIAL; GENETIC ENGINEERING; HEALTH CARE POLICY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SAFETY; VACCINATION; VACCINE PRODUCTION;

EVIDENCE-BASED MEDICINE; HEALTH POLICY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; VACCINATION;

EID: 0029816537     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.313.7060.768     Document Type: Editorial

References (5)

1. BBC Radio 4. One O'clock News, 1996;14 Sept.
2. Kane MA. Global status of hepatitis B immunisation. Lancet 1996; 348: 696.
3. Bonn D. Getting under the skin with melanoma vaccines. Lancet 1996; 348: 396.
4. Galloway D. Papillomavirus oncoproteins as vaccine candidates. Lancet 1996; 347: 1498.
5. Fedson DS, Hannoun C, Leese J, Sprenger MJW, Hampson AW, Bro-Jorgensen A-M, et al. Influenza vaccination in 18 developed countries, 1980–1992. Vaccine 1995; 13: 623–627.